August 3, 2021
Shionogi’s first-quarter sales diminished 3.4% year on year as a plunge in Crestor (rosuvastatin) royalties dealt a huge blow to its earnings, wiping out growth in ethical drug sales at home, according to its financial results released on August 2...read more